JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on January 3, 2007; DOI: 10.1124/jpet.106.113498


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.113498v1
321/1/318    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rose, J. L.
Right arrow Articles by Hoyt, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rose, J. L.
Right arrow Articles by Hoyt, D. G.


Received for publication September 6, 2006.
Revised December 28, 2006.
Accepted for publication December 29, 2006.

Base Excision Repair Proteins are Required for Integrin-Mediated Suppression of Bleomycin-Induced DNA Breakage in Murine Lung Endothelial Cells

Jane L. Rose 1, Kevin C. Reeves 2, Rostislav I. Likhotvorik 2, Dale G. Hoyt 2*

1 University of Pittsburgh 2 The Ohio State University

* Address correspondence to: E-mail: hoyt.27{at}osu.edu

Abstract

Engagement of integrin cell adhesion receptors suppresses bleomycin (BLM)-induced DNA strand breakage in endothelial cells. Previous investigation of cells from poly(ADP-ribose) polymerase-1 (PARP-1) knockout mice, and with an inhibitor of the enzyme, indicated that this facilitator of base excision repair (BER) is required for integrin-mediated suppression of DNA strand breakage. Here, small inhibitory RNA (siRNA) was used to assess the requirement for the BER proteins, DNA ligase III (Lig3) {alpha}, PARP-1, and XRCC1, and for the long-patch BER ligase, DNA ligase I (Lig1), in integrin-mediated protection from BLM-induced DNA breakage. Murine lung endothelial cells (MLEC) were transfected with siRNA, treated with anti-{beta}1 integrin antibody, and then BLM. 3'OH in DNA and accumulation of phosphorylated histone H2AX ({gamma}H2AX), which reflects double-strand breakage, were measured. Integrin antibody inhibited the increases in 3'OH caused by BLM in MLEC transfected with either control or Lig1 siRNA. However, after knockdown of Lig3{alpha}, PARP-1 or XRCC1, suppression of DNA breakage by integrin antibody was limited. BLM increased {gamma}H2AX levels, and integrin treatment inhibited this by 57 to 73% in MLEC transfected with control siRNA. Integrin engagement also inhibited increases in {gamma}H2AX in BLM-treated cells transfected with Lig1 siRNA. In contrast, Lig3{alpha}, PARP-1 and XRCC1 siRNAs prevented integrin-mediated inhibition of BLM-induced {gamma}H2AX levels. The results suggest that the BER proteins, Lig3{alpha}, PARP-1 and XRCC1, are required for integrin-mediated suppression of BLM-induced DNA breakage.


Key words: Bleomycin, DNA ligase, H2AX, Integrin, PARP-1, XRCC1


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
M. Artwohl, A. Lindenmair, V. Sexl, C. Maier, G. Rainer, A. Freudenthaler, N. Huttary, M. Wolzt, P. Nowotny, A. Luger, et al.
Different mechanisms of saturated versus polyunsaturated FFA-induced apoptosis in human endothelial cells
J. Lipid Res., December 1, 2008; 49(12): 2627 - 2640.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
T. Liu, Y. Huang, R. I. Likhotvorik, L. Keshvara, and D. G. Hoyt
Protein Never in Mitosis Gene A Interacting-1 (PIN1) regulates degradation of inducible nitric oxide synthase in endothelial cells
Am J Physiol Cell Physiol, September 1, 2008; 295(3): C819 - C827.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.